Previous studies using serum samples of PDAC patients who were newly diagnosed showed that the combination of LRG1, TIMP1 and CA19-9 biomarkers increased the accuracy of pancreatic cancer detection by 13.2% with a specificity greater than 99%, as compared to that using CA19-9 alone [14]. Here, TIMP1 is linked to pancreatic neoplasm.